Shareholders have already approved a pay increase for British American Tobacco chief executive Tadeu Marroco. He could ...

The head of Britain’s largest drug company has demanded Europe ramp up spending on medicines amid fears over Donald Trump’s ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

If the tariff-loving Trump goes ahead with his plans, it will hit AstraZeneca - the most valuable company on the UK stock ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Many drugs use active ingredients that are manufactured outside the U.S., among them the anticoagulant heparin, which 12 million patients use each year. Meanwhile, AstraZeneca's Chairman Michel Demaré ...

A string of pharmaceutical bosses attended a three-hour dinner at Donald Trump’s Mar-a-Lago resort in Florida in December.

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

Emma Raducanu faces a short-term slide down the WTA rankings as she takes a short break from action. The British No. 2 shot up the leaderboard with her excellent performances at the Miami Open but ...

Dame Emma Walmsley, DBE GlaxoSmithKline and Ben Wilson, National Grid at 10 Downing Street in London, after US President Donald Trump slapped a 10% tariff on US imports of UK goods. Picture date ...

In February, CEO Emma Walmsley announced that Q4 sales had beaten ... This being the case, I would never buy a slice of GSK or anything else based purely on what it spews out.